producing ␣-cells are the second-most abundant cell type in the islet. Whereas ␣-cells make up less than 20% of the cells in a mature mouse islet, they occupy a much larger proportion of the pancreatic endocrine cell population during the early postnatal period, the time when morphological and functional maturation occurs to form adult islets. To determine whether ␣-cells have a role in postnatal islet development, a diphtheria toxin-mediated ␣-cell ablation mouse model was established. Rapid and persistant depletion of ␣-cells was achieved by daily injection of the toxin for 2 wk starting at postnatal day 1 (P1). Total pancreatic glucagon content in the ␣-cell-ablated mice was undetectable at P14 and still less than 0.3% of that of the control mice at 4 mo of age. Histological analyses revealed that formation of spherical islets occurred normally, and the islet size distribution was not changed despite the near-total lack of ␣-cells. Furthermore, there were no differences in expression of ␤-cell maturation marker proteins, including urocortin 3 and glucose transporter 2, in the ␣-cell-ablated islets at P14. Mice lacking ␣-cells grew normally and appeared healthy. Both glucose and insulin tolerance tests demonstrated that the ␣-cell-ablated mice had normal glucose homeostasis. These results indicate that ␣-cells do not play a critical role in postnatal islet morphogenesis or functional maturation of ␤-cells.
ISLETS OF LANGERHANS ARE A MICROORGAN composed of four main types of endocrine cells: glucagon-producing ␣-cells, insulinproducing ␤-cells, somatostatin-producing ␦-cells, and pancreatic polypeptide (PP)-producing cells. In addition, a fifth type, ghrelin-producing ε-cells, is seen mostly in embryonic islets. In mature mouse islets, ␤-cells predominate (ϳ80% of total endocrine cells) and form a core of cells, whereas the secondmost abundant ␣-cells localize to the mantle of the islet along with ␦-cells and PP cells. This cellular arrangement is important for properly coordinated reciprocal secretion of insulin and glucagon for glucose homeostasis (42) .
During embryogenesis, pancreatic endocrine precursor cells arise from pancreatic epithelial cells that express the transcription factor neurogenin 3 (Ngn3) (16, 20) . Subsequently, specification of the five types of endocrine cells occurs within this Ngn3-positive population (15, 33) . This endocrine cell neogenesis occurs largely during embryonic stages, as evidenced by the presence of very few Ngn3-positive cells in the postnatal and adult pancreas (14, 16, 31) . The newly formed endocrine cells accumulate along the ducts and blood vessels in a cordlike linear pattern (15) and then undergo rapid expansion by self-replication in the perinatal period (3, 14) . Dynamic morphogenesis and functional maturation of islets proceed postnatally. It is noteworthy that although ␣-cells make up Ͻ20% of mature islet cells in mice, they occupy a much larger proportion of the pancreatic endocrine cell population during the early postnatal period (30) . In addition, the majority of ␣-cells are located within the outer rim of the developing endocrine pancreas.
The preproglucagon (Gcg) gene is expressed in pancreatic ␣-cells, enteroendocrine L cells, and a subset of neurons in the nucleus tractus solitarius in the hindbrain. The proglucagon peptide is cleaved by prohormone convertase 2 (PC2) to produce glucagon in ␣-cells (35) , whereas it is processed to other peptides, including glucagon-like peptide-1 (GLP-1), a known growth and survival hormone for ␤-cells (9) , by PC1/3 in L cells and neurons (25, 34) . Although differential processing is highly tissue specific, GLP-1 production was reported to occur in the pancreas of fetal and neonatal rats (24) and in human ␣-cells (29) . Because systemic GLP-1 that is secreted by L cells has a short half-life, only very small amounts of bioactive GLP-1 are expected to reach the pancreas. Thus, locally secreted GLP-1 within islets might have a more important effect on ␤-cells, although the actual amount of peptide is low. Beyond these proglucagonderived peptides, there may be unidentified ␣-cell-derived paracrine factors or mechanisms by which ␣-cells influence islet formation and function.
In this study, we sought to determine whether ␣-cells play a role in postnatal islet morphogenesis and maturation. Previously, models have been published with reduced or absent ␣-cells. In these other models, transcription factor misexpression or inactivation either diverted the fate of ␣-cell progenitors to other endocrine cell fates during embryogenesis (5, 18) or else forced differentiated ␣-cells to transdifferentiate into other endocrine cell types (6, 45) . In those studies, the cells that were originally destined to become ␣-cells but were diverted to form other cell types still existed in a different form. Thus, a specific role for ␣-cells may be difficult to determine exactly. Here, we used a diphtheria toxin (DT)-mediated cell "suicide" mechanism to ablate the ␣-cell lineage and demonstrated that ␣-cells are dispensable in postnatal islet formation and maturation.
MATERIALS AND METHODS

Generation of Gcg-Cre mice.
A murine Gcg gene fragment that included 8 kb of 5=-flanking sequence, exon 1, and exon 2 was derived from a bacterial artificial chromosome (BAC) clone RP24-439G8 (BACPAC Resources Center, Oakland, CA). The codon-improved Cre recombinase coding sequence (37) was cloned into the Gcg translation initiation site located in exon 2, followed by an adenylation signal sequence (Fig. 1A) . Because of size constraints, the 2,997-bp first intron was replaced with a 300-bp synthetic intron obtained from plasmid pIRES-EGFP (Clontech Laboratories, Mountain View, CA). BAC recombineering (44) was used to assemble the transgene construct. The DNA fragment was microinjected into the pronucleus of C57BL/6-inbred zygotes by the University of Pittsburgh Transgenic Core. Tail DNA from potential founder mice was screened by PCR analysis for the transgene integration (Fig. 1B) . Among three independent founder lines, line 23 was selected by an initial analysis of Cre expression in ␣-cells and used in this study.
Mouse strains and husbandry. All animal handling and experimental procedures were performed according to protocols and guidelines approved by the University of Pittsburgh Institutional Animal Care and Use Committee. Cre-inducible DT receptor (iDTR) mice (4) were originally obtained from Dr. Ari Waisman, and some breeders purchased from The Jackson Laboratory (Bar Harbor, ME) were subsequently added to the colony. Cre reporter strain, Rosa26mT/mG (R26mTmG) mice (32) , and Rosa26CAG-tdTomato (R26CAG-Tomato) mice (28) were purchased from The Jackson Laboratory. Homozygous iDTR mice or Cre reporter mice were bred to hemizygous Gcg-Cre mice to obtain Gcg-Cre/iDTR, Gcg-Cre/R26mTmG, or Gcg-Cre/R26CAG-Tomato double-transgenic mice. Littermates without Cre were used as a control. For studies on postnatal mice, data obtained from male and female animals were mixed for analyses. In studies with adult mice, either male or female animals were used as indicated.
Histological analyses. Pancreata were fixed by a transcardiac perfusion of 4% paraformaldehyde in PBS, followed by an overnight immersion in the same fixative. Cryosections (6 m) were used for all histological analyses described in this study. Primary antibodies used are listed in Table 1 . For immunofluorescent staining, cyanine dye-or DyLight dye-conjugated secondary antibodies were obtained from Jackson Immunoresearch (West Grobe, PA). To measure the size of ␤-cell area in each islet and number of islets, sections at 120-m intervals from whole pancreas were immunostained for insulin using the ABC kit (Vector Labs, Burlingame, CA) and analyzed using Image J software.
Physiological assessments. Blood glucose levels were measured using an Accu-Chek glucose meter (Roche, Indianapolis, IN). Plasma insulin levels were determined with an insulin ELISA kit (Alpco, Salem, NH). Plasma glucagon levels were determined with a glucagon RIA kit (Millipore, Billerica, MA), following the manufacturer's instructions, but with some modifications that were evaluated originally at the Vanderbilt Diabetes Research and Training Center (Wendell Nicholson, personal communication) to increase assay sensitivity. Briefly, glucagon antibody solution and 125 I-glucagon solution were diluted with 2 volumes of assay buffer, and the incubation time with the antibody was extended to two overnights. Standard curve range was 6.25-200 pg/ml with these modifications. For intraperitoneal glucose tolerance test (IPGTT) and insulin tolerance test (IPITT), mice were fasted for 16 (for IPGTT) or 6 h (for IPITT) and injected with glucose (2 g/kg) or human insulin (1 U/kg; Lilly, Indianapolis, IN), respectively.
Pancreatic hormone content. Pancreatic hormones were extracted from whole pancreas with 14 ml of acid ethanol. The extracts were further diluted 1/20 to 1/2,000. Insulin and glucagon concentrations in the diluted extract were determined using insulin RIA and glucagon RIA kits (Millipore), respectively. The lower limit of quantification of total pancreatic glucagon contents was 1.75 ng/pancreas when the modified protocol described above was applied.
Statistical analyses. Data are expressed as means Ϯ SD. Comparisons involving two groups were performed using the Student t-test, and those involving repeated measurements were performed using the two-way ANOVA. P Ͻ 0.05 was considered statistically significant. Differences with P Ն 0.05, but Ͻ0.1, were reported as a trend.
RESULTS
Establishment of the ␣-cell ablation mouse model. iDTR mice have a loxP-flanked STOP cassette preventing Rosa26 promoter-driven transcription of DTR (4) and have been successfully used for Cre-dependent, DT-induced cell ablation in a variety of cell types, including pancreatic cells (7) . To ablate pancreatic ␣-cells in iDTR mice, we generated glucagon-Cre (Gcg-Cre) transgenic mice carrying an improved Cre recombinase gene (37) driven by an 8-kb mouse Gcg gene promoter (Fig. 1A) .
We first examined Cre expression in the Gcg-Cre mice by performing immunostaining for Cre in pancreatic sections obtained from mice of various ages. Cre staining was readily detected in glucagon-positive cells on embryonic day (E)12.5, a time during the first wave of endocrine cell differentiation (15) , and we observed Cre expression in most glucagonpositive cells throughout the embryonic stages (Fig. 1C) . Furthermore, the Cre staining was confined to glucagon-positive cells at all ages examined, although Cre staining was not detected in 30 -50% of glucagon-positive cells examined in the neonatal and adult pancreata [Ͼ100 cells/pancreas, n ϭ 4 on postnatal day 7 (P7), n ϭ 3 in adults]. Since cell ablation in the iDTR system occurs not only in Cre-expressing cells but also in their progeny in which Cre may no longer be expressed, it is important to define the Cre positive-cell lineage. Therefore, we determined the Gcg-Cre-positive cell lineage using the Cre reporter mouse strain R26mTmG, in which Cre-mediated recombination of the mTmG gene marks Cre-expressing cells and their progeny by permanent conversion from expression of a membrane-targeted tomato red to membrane-targeted green fluorescent protein (GFP). In all ages examined, almost all ␣-cells (Ͼ98%) were GFP positive (Ͼ50 ␣-cells/pancreas, 3-5/group). Furthermore, in Gcg-Cre/Rosa26mTmG doubletransgenic mouse embryos, only glucagon-positive cells were GFP positive, indicating that the Gcg-Cre transgene expression was specific to the ␣-cell lineage in embryonic pancreata (Fig.  1D ). In contrast, 5-10% of ␤-cells examined were found to be GFP positive in the P1 pancreata (Ͼ100 ␤-cells/pancreas; n ϭ 4). The number of GFP-positive ␤-cells increased with age (12 Ϯ 3% in the P7-P14 pancreata), and 40 Ϯ 10% of ␤-cells examined were GFP positive in adult islets (Ͼ350 ␤-cells/ pancreas, n ϭ 5 in P7-P14, n ϭ 5 in adults). Thus, although this Gcg-Cre mouse line may not be ideal for performing ␣-cell ablation in adult mice due to coablation of a substantial number of ␤-cells during ␣-cell ablation, we thought that an incidental coablation of ␤-cells would only minimally affect our studies on neonatal mice, if at all. It remains unclear whether the postnatal GFP-positive ␤-cells are due to leaky expression of the Gcg-Cre transgene or whether these cells did in fact express glucagon earlier in their lineage.
Since the 8-kb Gcg gene fragment used to direct Cre expression includes promoter elements required for Gcg gene expression in neurons and enteroendocrine L cells as well as ␣-cells, we examined the brain of 4-mo-old Gcg-Cre/ R26mTmG mice. Cre lineage labeling with GFP was detected in some clusters of neurons in the brainstem, where neurons producing proglucagon-derived peptides have been reported ( Fig. 2A) . We used the R26mTmG mouse strain as a Cre reporter to characterize our Gcg-Cre transgenic mice for most of this study. Although labeling both Cre-negative and Crepositive cells with fluorescence proteins (red and green, respectively) in this reporter system could avoid false positive or negative results, the system leaves only relatively weak fluorescent dyes as an option for immunofluorescent staining on the background of reporter fluorescence. Because immunostaining for GLP-1 requires a secondary antibody with a strong dye, we used the R26CAG-Tomato mouse strain instead of R26mTmG mouse strain to examine expression of the Gcg-Cre transgene in enteroendocrine L cells. In the distal ileum of a 10-day-old Gcg-Cre/R26CAG-Tomato reporter mouse, L cells were double positive for GLP-1 immunostaining and Cre lineage labeling with red fluorescence protein (Fig. 2B) . In contrast to pancreatic ␣-cells, GLP-1-positive cells were inconsistently Cre-lineage tagged (Fig. 2C) .
␣-Cell ablation in neonatal mice requires prolonged treatment with DT. Since 5 days of treatment with DT was sufficient to ablate ␣-cells completely in adult Ngn3-Cre/iDTR mice as well as in adult Gcg-Cre/iDTR mice (data not shown), we first applied a similar regimen to Gcg-Cre/iDTR neonates as well as to Cre-negative iDTR littermates, which served as a control. To avoid neglect of newborns by the dam, five daily treatments (10 ng·mouse Ϫ1 ·day Ϫ1 sc) were started at P1 instead of P0, and the glucagon content of the pancreas was measured on P7, P14, P21, and 4 mo of age. The glucagon content decreased significantly in DT-treated Gcg-Cre/iDTR mice compared with iDTR mice at all ages examined (Fig. 3A) . However, Gcg-Cre/ iDTR pancreata still contained 7.5% of the normal level of glucagon at P7, indicating that the ablation was incomplete. Notably, although the pancreatic glucagon content increased with age in DT-treated Gcg-Cre/iDTR mice, it remained at 10% of the normal level at 4 mo of age, suggesting that the growth rate of surviving ␣-cells was proportional to that of all ␣-cells in control mice and that no "catchup" growth of ␣-cells occurred.
Consistent with a decrease in glucagon content, immunostaining of tissue sections demonstrated that the number of glucagon-positive cells decreased drastically in the DT-treated Gcg-Cre/iDTR pancreas compared with the iDTR pancreas at P4 (Fig. 3B) . About 13% of the insulin-positive cells examined were bromodeoxyuridine (BrdU)-positive in both Gcg-Cre/ iDTR and iDTR pancreases, when mice were injected with BrdU (50 g·injection Ϫ1 ·g Ϫ1 , 3 injections at 2-h intervals)
prior to tissue harvest (Ͼ400 ␤-cells/pancreas; n ϭ 2/group). Glucagon-positive cells were also frequently labeled with BrdU in the iDTR pancreas. Notably, some remaining glucagon-positive cells in the DT-treated Gcg-Cre/iDTR pancreas were BrdU positive, indicating that the incomplete ablation in early postnatal mice may be accompanied by continued proliferation of the few cells that were not ablated. To achieve complete ablation, we extended DT treatment to P14. This 2-wk treatment reduced pancreatic glucagon content to undetectable levels in Gcg-Cre/iDTR mice on P14 and P21 (Fig. 3A) . Although glucagon content was below the detection range by RIA using whole pancreas extract, there were still some ␣-cells seen in immunostained tissue sections. Therefore, we counted insulin-positive and glucagon-positive cells on coronal pancreatic sections that included the core region of the pancreatic tail as well as some of the head. The number of ␤-cells per section decreased postnatally by P21 and then increased in adult mice (Fig. 3C ). This transient decrease of ␤-cell number per section was most likely due to faster expansion of the exocrine cell population and due to migration of islets from the core to peripheral region of the organ at this postnatal period. There was no difference in the number of ␤-cells per section between DT-treated iDTR and Gcg-Cre/ iDTR mice at all ages examined. In contrast, whereas ␣-cells occupied 33.0 Ϯ 8.2% of the total ␣-and ␤-cell population in iDTR mice, it was only 2.6 Ϯ 5.1% in Gcg-Cre/iDTR mice on P21 (Fig. 3C) . Despite the nearly complete loss of ␣-cells, DT-treated Gcg-Cre/iDTR mice grew normally and appeared healthy. At 2 mo of age, there was no significant difference in body weight between iDTR and Gcg-Cre/iDTR mice (24.7 Ϯ 0.4 vs. 26.1 Ϯ 1.0 in males, 19.0 Ϯ 0.3 vs. 18.7 Ϯ 1.2 in females; n ϭ 7/group). At 4 mo of age, the pancreatic glucagon content in Gcg-Cre/iDTR mice became detectable, but it was Ͻ0.3% of that of control mice (Fig. 3A) . Consistently, the number of ␣-cells in DT-treated Gcg-Cre/iDTR mice was 1.4 Ϯ 1.2% of that in iDTR mice at 4 mo of age (Fig. 3C) . We used these mice treated with the 2-wk regimen of DT as our postnatal ␣-cell ablation model in this study.
Postnatal morphogenesis of islets occurs normally despite a near total lack of ␣-cells. To determine whether the ablation of ␣-cells has any impact on postnatal islet formation, we examined the morphology of islets at various ages during and after DT treatment. At P4, the majority of endocrine cells aggregated along ducts to form cord-like structures where ␣-and ␦-cells localize to the outer rim in the control iDTR mouse pancreas (Fig. 4, A and B) . PP-positive cells were also seen in the outer rim of immature islets, and some ␤-cells were costained with PP antibody. In the Gcg-Cre/iDTR mouse pancreas that had been treated with DT for 3 days, most ␣-cells were already ablated, with only a few cells seen, but no changes were detected in either the shape of the islets or the distribution of ␦-cell and PP cell types (Fig. 4, C and D) . On P14, the ␤-cell area had expanded normally in the Gcg-Cre/ iDTR pancreas, as seen in the controls despite an almost complete loss of ␣-cells (Fig. 4, E-H) . In adults, spherical islets with ␦-cells and PP cells present at the periphery were observed in Gcg-Cre/iDTR mouse pancreas, as seen in control pancreas (Fig. 4, I-L) . Notably, ␦-cells and PP double-positive cells were more frequently seen in islets that lacked ␣-cells (Fig. 4L) . However, there was no significant difference in the number of ␦-cells and PP cells between iDTR and Gcg-Cre/ iDTR mice (207 Ϯ 125 ␦-cells and 223 Ϯ 110 PP cells per iDTR mouse pancreatic section vs. 280 Ϯ 94 ␦-cells and 292 Ϯ 99 PP cells per Gcg-Cre/iDTR mouse pancreatic section at 4 mo of age; n ϭ 3/group). In addition, no ghrelin-positive (ε)-cells were detected by immunostaining in Gcg-Cre/iDTR mouse pancreata, as in iDTR mouse pancreata (data not shown).
Morphometric analysis of insulin-positive area on sections showed similar size distribution of ␤-cell area of each islet between iDTR and Gcg-Cre/iDTR pancreata either on P21 or at 4 mo of age, further indicating normal islet morphogenesis in ␣-cell-ablated pancreas (Fig. 5A) . Insulin content in the ␣-cell-ablated pancreas was not different from that in the control pancreas on P4, P7, P14, and P21 but was increased in 4-mo-old mice. This increase was proportional to changes in pancreas weight (Fig. 5B) . Insulin-positive area made up 0.59 Ϯ 0.11% of the total pancreatic area in iDTR mice and 0.52 Ϯ 0.21% in Gcg-Cre/iDTR mice on P21 and then 0.48 Ϯ 0.05% in iDTR mice and 0.62 Ϯ 0.29% in Gcg-Cre/iDTR mice at 4 mo of age. A comparable ratio of insulin-positive area to the total pancreatic area between iDTR and Gcg-Cre/iDTR mice, together with the data of pancreas weight and pancreatic insulin content (Fig. 5B) , indicates that ␤-cell mass in postnatal mice was not substantially changed by ␣-cell ablation and that the ␤-cell mass increased only proportionally to the increase in pancreas weight that occurred in the ␣-cell-ablated pancreas at 4 mo of age. Increased pancreatic size seems to be a result of glucagon insufficiency, since the same phenotype has been reported in mice lacking glucagon signaling either by Gcg gene null mutation (19) or by Gcgr gene null mutation (13) . B: triple immunofluorescent staining was performed for glucagon (green), insulin (blue), and bromodeoxyuridine (BrdU; red) in pancreata from iDTR and Gcg-Cre/iDTR mice at P4 after 3 daily injections of DT. Color channels for glucagon and insulin are shown in separate panels. Glucagon ϩ BrdU ϩ cells are seen in both iDTR and Gcg-Cre/iDTR pancreata (arrows). Scale bars, 50 m. C: no. of ␤-and ␣-cells in iDTR and Gcg-Cre/iDTR mouse pancreata during or after daily DT treatments from P1 to P14. Insulin-and glucagon-positive cells in immunostained pancreatic sections were counted. Data are shown as means Ϯ SD per section (n ϭ 3/group). P Ͻ 0.0001, ␣-cell nos. in iDTR vs. those in Gcg-Cre/iDTR by a 2-way ANOVA.
Functional maturation of ␤-cells progressed normally in
␣-cell-ablated islets. We further examined whether maturation of ␤-cells was affected in Gcg-Cre/iDTR mouse islets by immunostaining for markers of ␤-cell maturation. Urocortin 3 (Ucn3), a marker for postnatal maturation of ␤-cells (2), was detected in P14 Gcg-Cre/iDTR islets, similar to iDTR islets (Fig. 6A ). In addition, there was no difference in staining for glucose transporter 2 (GLUT2), a molecule necessary for glucose sensing, between the iDTR and Gcg-Cre/iDTR islets (Fig. 6A) . Transcription factors Pdx1, NeuroD, and MafA, which are all known to be necessary for ␤-cell differentiation and maturation (15) , were also detected by immunostaining in P14 Gcg-Cre/iDTR islets, similar to iDTR islets (Fig. 6B) . These data indicate that functional maturation of ␤-cells is not affected by ␣-cell deficiency.
␣-Cell-ablated mice displayed resistance to fasting-induced hypoglycemia, but otherwise glucose homeostasis is minimally affected. As mentioned earlier, ␣-cell-ablated mice grew normally and appeared healthy. We further investigated whether the ␣-cell ablation in neonatal mice may affect glucose homeostasis in adulthood. Blood glucose levels measured between 7 and 9 AM were 169.2 Ϯ 15.6 mg/dl in male iDTR, 157 Ϯ 17.2 mg/dl in male Gcg-Cre/iDTR, 151.1 Ϯ 16.2 mg/dl in female iDTR, and 145.5 Ϯ 2.3 mg/dl in female Gcg-Cre/iDTR mice at 4 wk of age and 162.0 Ϯ 15.2 mg/dl in male iDTR, 166.0 Ϯ 2.3 mg/dl in male Gcg-Cre/iDTR, 154.1 Ϯ 11.3 mg/dl in female iDTR, and 145 Ϯ 13.4 mg/dl in female Gcg-Cre/iDTR mice at 8 wk of age. There was no significant difference between the control and ␣-cell-ablated mice at either age nor between either sex. We next monitored blood glucose levels in 4-mo-old mice during a 24-h fast. The control mice displayed a gradual decline of blood glucose levels during the fasting period, and the level was reduced by 48% from the initial level after 24 h of fasting (Fig. 7A) . In contrast, Gcg-Cre/iDTR mice were able to sustain their glucose level during the first 12 h of fasting, indicating that they were more resistant to fastinginduced hypoglycemia than the control mice. However, there was no difference in glucose levels after the 24 h of fasting between iDTR and Gcg-Cre/iDTR mice.
Plasma insulin levels after 2 h of fasting were not significantly different between DT-treated iDTR and Gcg-Cre/iDTR mice (Fig. 7B ). In addition, there was no significant difference in the plasma insulin response to 24 h of fasting (37% reduction in iDTR mice vs. 35% reduction in Gcg-Cre/iDTR mice). However, it is noteworthy that plasma insulin levels in GcgCre/iDTR mice trended toward being lower than in iDTR mice after 24 h of fasting (P ϭ 0.095). Plasma glucagon levels were drastically decreased in DT-treated Gcg-Cre/iDTR mice compared with control mice, as expected (Fig. 7C) . IPGTT demonstrated that DT-treated Gcg-Cre/iDTR mice were normal in glucose disposal at 4 mo of age (Fig. 7D) . In addition, a slight increase in insulin sensitivity was observed in Gcg-Cre/iDTR mice compared with iDTR mice during first 30-min period of IPITT (Fig. 7E) .
To further evaluate islet function in ␣-cell-ablated mice, we measured plasma insulin levels immediately before and 10 -15 min after glucose challenge (2 g/kg ip) in 6-h-fasted DT-treated iDTR and Gcg-Cre/iDTR mice at 8 wk of age. Both iDTR and Gcg-Cre/iDTR mice demonstrated insulin response to acute hyperglycemia (557 Ϯ 42 mg/dl in male iDTR, 577 Ϯ 40 mg/dl in male Gcg-Cre/iDTR, 513 Ϯ 49 mg/dl in female iDTR, and 547 Ϯ 61 mg/dl in female Gcg-Cre/iDTR mice), although a significant increase in plasma insulin levels was observed only in females (Fig. 7F) . There was no difference between the control and ␣-cell-ablated mice in the fold increase of plasma insulin levels after glucose challenge, indicating the normal insulin response to glucose in ␣-cell-ablated mice (Fig. 7G) .
Overall, these data indicate that postnatal ␣-cell ablation does not greatly affect ␤-cell function in adulthood and suggest that whole body glucose homeostasis may be maintained by mechanisms that compensate for glucagon insufficiency.
DISCUSSION
Previous morphometric studies showed that mature islets were formed through the growth of smaller islets and through fission of large interconnected islet-like structures during the postnatal period (22, 30, 36) . A contribution of ␣-cells to this fission process has been postulated based on the presence of ␣-cells at the putative cleavage points (30) . However, our studies described here demonstrate that the islet size distribution evaluated by insulin staining was not changed in ␣-cellablated pancreata, indicating that postnatal islet morphogenesis can proceed in the absence of ␣-cells. The similar pancreatic insulin content and ␤-cell number between ␣-cell-ablated pancreas with control pancreas during the postnatal period is further evidence that ␤-cells can grow normally without any influence from ␣-cells. Our results are consistent with a recent study by Yang et al. (45) , who described normal islet formation in mice that expressed Pdx1 ectopically in the Ngn3-positive cell lineage and had loss of ␣-cells postnatally because of ␣-cell to ␤-cell conversion. Our study provides further direct evidence that ␣-cells are not required for islet formation.
Pancreatic ␤-cells are functionally immature in newborn mice, and maturation occurs during the postnatal period. Blum et al. (2) demonstrated that immature ␤-cells are characterized by a lower threshold for glucose-stimulated insulin secretion (GSIS) and that ␤-cells acquire a mature GSIS capacity by P9. That study also revealed that, whereas the RNA expression level of most of the genes required for glucose sensing and insulin secretion does not change more than twofold, the expression of Ucn3 increases more than sevenfold during the time window of ␤-cell maturation. Thus, our comparable staining for Ucn3, in addition to GLUT2, Pdx1, NeuroD, and MafA, in the control and ␣-cell-ablated islets on P14 indicates that functional maturation of ␤-cells takes place in the appropriate time frame despite the absence of ␣-cells.
Although ␤-cells appeared normal, double-hormone-positive cells for somatostatin and PP were seen frequently in ␣-cell-ablated islets. Previously, cell lineage analyses showed that PP-positive embryonic islet cells could be a precursor of ␦-cells (21). Our results may indicate that ␣-cells promote A B Fig. 5 . Postnatal ablation of ␣-cells does not affect islet size distribution but increases pancreatic insulin content in adulthood. A: size distribution of ␤-cell area in each islet was determined by morphometric analysis in male iDTR and Gcg-Cre/iDTR pancreata at P21 and 4 mo (4M) of age. Data are shown as means Ϯ SD (n ϭ 3/group). B: pancreatic weight and insulin content were measured in iDTR and Gcg-Cre/iDTR mice at P4, P7, P14, P21, and 4M. Both sexes were used for measurement at P4 -P21, whereas only males were used at 4M. Data are shown as means Ϯ SD (n ϭ 3-6/group). ***P Ͻ 0.005 vs. iDTR.
terminal differentiation of ␦-cells. Similar double-hormonepositive cells were reported in myelin transcription factor 1-null mutant mice (43) . In this study, ␣-cell-ablated mice did not display hypoglycemia despite a near total lack of ␣-cells and extremely low levels of plasma glucagon. This is contrast to Gcgr-null mutant mice, which were reported to have significant hypoglycemia (13) . Conversely, ␣-cell-ablated mice demonstrated some resistance to fasting-induced hypoglycemia. Mechanisms to compensate for glucagon insufficiency and to resist fastinginduced hypoglycemia are not known. However, at least in part, other counterregulatory hormones, in addition to the adjustment of plasma insulin to a lower level, might be involved. Indeed, it was reported that Gcgr-null mutant mice had higher plasma cortisol levels and higher sensitivity to epinephrine (13) . In addition, an increased level of catecholamines was reported in mice that lack ␣-cells as a result of pancreasspecific deletion of the Arx gene, although this was not statistically significant (18) . Although ␣-cell-ablated mice appeared to develop mechanisms to resist hypoglycemia, paradoxically, these mice also showed a slight increase in insulin sensitivity during IPITT. Increased insulin sensitivity was also demonstrated by a hyperinsulinemic euglycemic clamp technique in Gcgr-null mice (27, 38) and pancreas-specific Arx gene knockout mice (18) . The explanation may be that reduced plasma insulin levels can augment insulin sensitivity in peripheral target organs regardless of blood glucose levels or that glucagon deficiency might modulate insulin signaling pathways directly.
Gcg-, Gcgr-, and prohormone convertase 2-null mice (11, 12) completely lack glucagon signaling and display a striking phenotype of ␣-cell hyperplasia. Recently, it was shown that the disruption of the Gcgr gene only in liver could recapitulate an ␣-cell hyperplasia phenotype (27) . Since adult Gcg-null mice had normal blood glucose levels, it was suggested that a lack of glucagon signaling in the liver, rather than sustained lower blood glucose levels, contributes to the development and maintenance of the ␣-cell hyperplasia (19) . Although ␣-cell hyperplasia develops mainly during the postnatal period in these mice (13, 19) , it can also be induced in adult mice by inhibiting glucagon signaling, as shown in mice treated with an anti-glucagon antibody (10) or an anti-glucagon receptor antibody (17) . Recently, ␣-cells were ablated in adult mice by Thorel et al. (40) . They used a DT-mediated cell ablation system similar to our system. In their model, although 98% of ␣-cells were ablated, the remaining ␣-cells maintained normal In this study, we developed a new glucagon-Cre transgenic mouse line. Although Cre was detected exclusively in glucagon-positive ␣-cells by immunostaining, a large population of ␤-cells in the adult pancreas was labeled by Cre lineage tracing. Although a recent study demonstrated that an extreme loss of ␤-cells induces transdifferentiation of ␣-cells to ␤-cells (41) , it was also shown that Ngn3-positive progenitors gave rise to only one type of endocrine cell (8) . Thus, it seems likely that a low-level expression of Cre, which was not detected by immunostaining, occurred in ␤-cells and was enough to recombine the mTmG Cre reporter gene. It is possible that this Cre expression mirrors actual Gcg gene activity and is not due . Postnatal ␣-cell ablation has minimal impact on glucose homeostasis. A: blood glucose levels were measured in 4-mo-old male mice during fasting at the times indicated. Data are shown as means Ϯ SD (n ϭ 10 -12/group). B and C: plasma insulin (B) and glucagon levels (C) were measured in 4-mo-old male mice during fasting at the times indicated. Data are shown as means Ϯ SD (n ϭ 7-11/group). D: intraperitoneal glucose tolerance test was performed in 4-mo-old fasted (16 h) male mice. No significant differences between iDTR and Gcg-Cre/iDTR mice were found before or after glucose (2 g/kg) administration. Data are shown as means Ϯ SD (n ϭ 7/group). E: intraperitoneal insulin tolerance test was performed in 4-mo-old male mice. Gcg-Cre/iDTR mice showed more rapid decrease in blood glucose level after insulin (1 U/kg) administration. Data are shown as mean Ϯ SD (n ϭ 7-8/group). F and G: in vivo insulin response to glucose. Plasma insulin levels (F) were measured before and after glucose challenge in 8-wk-old iDTR and Gcg-Cre/iDTR mice. Fold increase of insulin levels by glucose challenge is shown in G. Data are shown as means Ϯ SD (n ϭ 4/group). *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.005 vs. iDTR.
simply to "leakiness" of the transgene, since multiplex singlecell nested RT-PCR analysis showed that 11% of adult ␤-cells isolated from mice coexpress the Gcg gene (23) . Because of the high recombination frequency in ␤-cells in the adult pancreas of our mice, the utility of our Gcg-Cre line for studies on adult mice is limited. However, the high level of Cre expression in embryonic ␣-cells could make our line usable with less sensitive loxP conditional alleles in islet developmental studies.
We confirmed the expression of our Gcg-Cre in enteroendocrine L cells using a Cre reporter mouse. However, Cre lineage labeling was seen in only a small subset of L cells. This result suggests that the transgene promoter activity was relatively low in this cell type. In contrast to ␣-cells, whose neogenesis appears to be limited largely to the embryonic period, enterendocrine cells are constantly replenished from stem cells throughout life. Their lifespan was estimated to be only around 10 days (39) . Although number of L cells might be decreased during the actual DT treatment in our studies, a severe defect in GLP-1 was not expected due to the robust regenerative potential of L cells by neogenesis.
In conclusion, we have established a mouse model of postnatal ␣-cell ablation. A rapid and persistant ␣-cell depletion in neonatal mice enabled us to determine whether ␣-cells are necessary for normal postnatal islet morphogenesis and functional maturation by means of paracrine or direct cell-cell interaction mechanisms. Our results demonstrate that ␣-cells are not necessary for postnatal islet formation or for the functional maturation of ␤-cells in mice. In addition, our studies revealed that the depleted ␣-cells during the early postnatal period are not replenished at all, even after 4 mo. Mice lacking ␣-cells displayed resistance to fasting-induced hypoglycemia and mild pancreatic hypertrophy in adults, both of which can be explained by glucagon deficiency in these animals rather than the absence of ␣-cells.
